Curcumin-piperine/curcumin-quercetin/curcumin- silibinin dual drug-loaded nanoparticulate combination therapy: A novel approach to target and treat multidrug-resistant cancers

Journal of Medical Hypotheses and Ideas

Volumn 7, Issue 1, 2013, Pages 15-20

  Moorthi, C ^a   Kathiresan, K ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Curcumin; Multidrug resistant cancer; Nanoparticle; Piperine; Quercetin; Silibinin

Indexed keywords

BETA CYCLODEXTRIN; CURCUMIN; NANOPARTICLE; PIPERINE; POLOXAMER; QUERCETIN; SILIBININ;

ARTICLE; BIOAVAILABILITY; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; DRUG CLEARANCE; DRUG EFFICACY; DRUG METABOLISM; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG TARGETING; HUMAN; INTESTINE; LIVER METABOLISM; MULTIDRUG RESISTANCE; NONHUMAN;

EID: 84879008495     PISSN: 22517294     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmhi.2012.10.005     Document Type: Article

References (33)

1. Moorthi C, Kiran K, Manavalan R, Kathiresan K. Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles. Asian Pac J Trop Biomed 2012;2:841-8.
2. Yu HL, Huang QR. Enhanced in vitro anti-cancer activity of curcumin encapsulated in hydrophobically modified starch. Food Chem 2010;119:669-74.
3. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol 2007;595:1-75.
4. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007;4(6):807-18.
5. Tuttle S, Hertan L, Katz JS. Indian gold treating cancer in the age of nano. Cancer Biol Ther 2011;11(5):474-6.
6. Yang R, Zhang S, Kong D, Gao X, Zhao Y, Wang Z. Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin. Pharm Res 2012;29(12):3512-25.
7. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an "old-age"disease with an "age-old"solution. Cancer Lett 2008;267(1):133-64.
8. Ló pez-Lázaro M. Anti-cancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res 2008;52(1):103-27.
9. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 2011;10:12.
10. Thangapazham RL, Sharma A, Maheshwari RK. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 2006;8(3):443-9.
11. Moorthi C, Manavalan R, Kathiresan K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci 2011;14(1):67-77.
12. Mulik RS, Mönkkönen J, Juvonen RO, Mahadik KR, Paradkar AR. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anti-cancer activity by induction of apoptosis. Int J Pharm 2010;398(1-2):190-203.
13. Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, Tan G, et al. Curcumin-loaded c-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine 2012;8(4):440-51.
14. Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, et al. Preparation and characterization of water-soluble albuminbound curcumin nanoparticles with improved antitumor activity. Int J Pharm 2011;403(1-2):285-91.
15. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 2009;37(3-4):223-30.
16. Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, et al. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 2010;79(3):330-8.
17. Dilnawaz F, Singh A, Sahoo SK. Transferrin-conjugated curcumin-loaded superparamagnetic iron oxide nanoparticles induce augmented cellular uptake and apoptosis in K562 cells. Acta Biomater 2012;8(2):704-19.
18. Rajesh KG, Vinayak AD, Dimple K, Umesh TN, Rishi BS, Kale SN, et al. Conjugation of curcumin with PVP capped gold nanoparticles for improving bioavailability. Mater Sci Eng C 2012;32(8):2659-63.
19. Rejinold NS, Muthunarayanan M, Divyarani VV, Sreerekha PR, Chennazhi KP, Nair SV, et al. Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. J Colloid Interf Sci 2011;360(1):39-51.
20. Mulik RS, Mönkkönen J, Juvonen RO, Mahadik KR, Paradkar AR. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anti-cancer activity against neuroblastoma cells. Int J Pharm 2012;437(1-2):29-41.
21. Anitha A, Deepagan VG, Divya Rani VV, Deepthy M, Nair SV, Jayakumar R. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles. Carbohydr Polym 2011;84(3):1158-64.
22. Akhtar F, Rizvi MM, Kar SK. Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Biotechnol Adv 2012;30(1):310-20.
23. Liu Jinsong, Xu Lihua, Liu Chuantong, Zhang Dafeng, Wang Siqian, et al. Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake. Carbohydr Polym 2012;90:16-22.
24. Feng Runliang, Song Zhimei, Zhai Guangxi. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles. Int J Nanomed 2012;7:4089-98.
25. Mohanty C, Sahoo SK. The in-vitro stability and in-vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 2010; 31(25):6597-611.
26. Liu Yinghui, Sun Changshan, Hao Yanru, Jiang Tongying, Zheng Li, Wang Siling. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles. J Pharm Pharm Sci 2010;13(4):589-606.
27. Randhawa Gurpreet Kaur, Kullar Jagdev Singh, Rajkumar. Bioenhancers from mother nature and their applicability in modern medicine. Int J Appl Basic Med Res 2011;1(1):5-10.
28. Sunila ES, Kuttan G. Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. J Ethnopharmacol 2004;90(2-3):339-46.
29. Zhang H, Zhang M, Yu L, Zhao Y, He N, Yang X. Antitumor activities of quercetin and quercetin-50,8-disulfonate in human colon and breast cancer cell lines. Food Chem Toxicol 2012;50(5):1589-99.
30. Lu W, Lin C, King TD, Chen H, Reynolds RC, Li Y. Silibinin inhibits Wnt/b-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells. Cell Signal 2012;24(12):2291-6.
31. Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307(1):93-102.
32. Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 2007;9(2):128-47.
33. Rasheed A, Ashok Kumar CK, Sravanthi VVNSS. Cyclodextrins as drug carrier molecule: a review. Sci Pharm 2008;76:567-98.